Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aftab Ala

Showing results (51-60 of 72) with videos related to

Pageof 8
Sort By:
Lancet (London, England)|December 8, 2024
Harnessing faith-based organisations for global health equityAftab Ala, Morro M L Touray, Shuja Shafi, et al.
Hepatology (Baltimore, Md.)|July 28, 2021
Designing Clinical Trials in Wilson's DiseasePeter Ott, Aftab Ala, Frederick K Askari, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|August 31, 2020
Improving uptake of hepatitis B and hepatitis C testing in South Asian migrants in community and faith settings using educational interventions-A prospective descriptive studyClaire Kelly, Marinos Pericleous, Ayesha Ahmed, et al.
Journal of Hepatology|January 26, 2023
Risk of liver fibrosis associated with long-term methotrexate therapy may be overestimatedEdmond Atallah, Jane I Grove, Colin Crooks, et al.
Digestive Diseases and Sciences|July 11, 2013
Mucosal addressin cell adhesion molecule (MAdCAM-1) expression is upregulated in the cirrhotic liver and immunolocalises to the peribiliary plexus and lymphoid aggregatesAftab Ala, David Brown, Korsa Khan, et al.
The Lancet. Gastroenterology & Hepatology|October 10, 2017
Bis-choline tetrathiomolybdate in patients with Wilson's disease: an open-label, multicentre, phase 2 studyKarl Heinz Weiss, Frederick K Askari, Anna Czlonkowska, et al.
Clinical Medicine (London, England)|January 25, 2025
A mixed-methods evaluation of a novel targeted health messaging intervention to promote COVID-19 protective behaviours and vaccination among Black and South Asian communities living in the UK (the COBHAM study)Katie Sutton, Jo Armes, Lindsay Forbes, et al.
BMJ Open|April 11, 2023
Novel intervention to promote COVID-19 protective behaviours among Black and South Asian communities in the UK: protocol for a mixed-methods pilot evaluationLindsay Forbes, Jo Armes, Shuja Shafi, et al.
Journal of the Academy of Consultation-Liaison Psychiatry|May 27, 2021
The Effect of Mental Health, Neurological Disease, and Liver Disease on Quality of Life in Patients With Wilson DiseaseMichelle A Camarata, Aftab Ala, Ayse K Coskun, et al.
The Lancet. Gastroenterology & Hepatology|April 16, 2022
Investigation and management of Wilson's disease: a practical guide from the British Association for the Study of the LiverSamuel Shribman, Thomas Marjot, Abubakar Sharif, et al.
Pageof 8

Showing results (51-60 of 72) with videos related to

Sort By:
Pageof 8
Lancet (London, England)|December 8, 2024
Harnessing faith-based organisations for global health equityAftab Ala, Morro M L Touray, Shuja Shafi, et al.
Hepatology (Baltimore, Md.)|July 28, 2021
Designing Clinical Trials in Wilson's DiseasePeter Ott, Aftab Ala, Frederick K Askari, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|August 31, 2020
Improving uptake of hepatitis B and hepatitis C testing in South Asian migrants in community and faith settings using educational interventions-A prospective descriptive studyClaire Kelly, Marinos Pericleous, Ayesha Ahmed, et al.
Journal of Hepatology|January 26, 2023
Risk of liver fibrosis associated with long-term methotrexate therapy may be overestimatedEdmond Atallah, Jane I Grove, Colin Crooks, et al.
Digestive Diseases and Sciences|July 11, 2013
Mucosal addressin cell adhesion molecule (MAdCAM-1) expression is upregulated in the cirrhotic liver and immunolocalises to the peribiliary plexus and lymphoid aggregatesAftab Ala, David Brown, Korsa Khan, et al.
The Lancet. Gastroenterology & Hepatology|October 10, 2017
Bis-choline tetrathiomolybdate in patients with Wilson's disease: an open-label, multicentre, phase 2 studyKarl Heinz Weiss, Frederick K Askari, Anna Czlonkowska, et al.
Clinical Medicine (London, England)|January 25, 2025
A mixed-methods evaluation of a novel targeted health messaging intervention to promote COVID-19 protective behaviours and vaccination among Black and South Asian communities living in the UK (the COBHAM study)Katie Sutton, Jo Armes, Lindsay Forbes, et al.
BMJ Open|April 11, 2023
Novel intervention to promote COVID-19 protective behaviours among Black and South Asian communities in the UK: protocol for a mixed-methods pilot evaluationLindsay Forbes, Jo Armes, Shuja Shafi, et al.
Journal of the Academy of Consultation-Liaison Psychiatry|May 27, 2021
The Effect of Mental Health, Neurological Disease, and Liver Disease on Quality of Life in Patients With Wilson DiseaseMichelle A Camarata, Aftab Ala, Ayse K Coskun, et al.
The Lancet. Gastroenterology & Hepatology|April 16, 2022
Investigation and management of Wilson's disease: a practical guide from the British Association for the Study of the LiverSamuel Shribman, Thomas Marjot, Abubakar Sharif, et al.
Pageof 8